GSK3050002

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Autoimmune DiseasesColitis, Ulcerative

Phase 1

Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002

CompletedNCT01984047

GlaxoSmithKlineColitis, Ulcerative

Start: 2014-01-10End: 2015-02-23Updated: 2018-07-24

A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Arthritis

WithdrawnNCT02671188

GlaxoSmithKlineAutoimmune Diseases

Start: 2018-06-01End: 2019-08-09Updated: 2018-08-31